Tempo is a Healthtech company. It has raised $500M in total funding. Latest round: Series A. Backed by Thrive Capital, Greenoaks, Sequoia.
Tempo funding overview
Tempo is a Healthtech company. Tempo has raised $500M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series A announced in October 2025. The round record for Tempo runs through 2025; nothing later has been disclosed. Investors on record include Thrive Capital, Greenoaks, Sequoia, Ribbit Capital, SV Angel. 5 distinct backers are named across the disclosed rounds.
Tempo has raised $500M in total disclosed funding across the rounds on record.
Who has invested in Tempo?
Thrive Capital, Greenoaks, Sequoia, Ribbit Capital, SV Angel are named among the investors backing Tempo.
What was the latest Tempo funding round?
The most recent disclosed round is a Series A, announced in October 2025.
Where is Tempo based?
No headquarters location is disclosed for Tempo.
What sector does Tempo operate in?
Tempo is tracked under Healthtech, with $500M in disclosed funding.
When did Tempo last raise?
The last disclosed Tempo round closed in October 2025 at Series A.
Totals shown for Tempo aggregate every disclosed round on file. To see how that compares, browse the Healthtech companies and the investors behind them below.
